Aevi Genomic Medicine (LSE:MEDU) Market Cap : £73.37 Mil (As of May. 03, 2024)

Aevi Genomic Medicine Market Cap Chart

Aevi Genomic Medicine Annual Data
	Trend	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18
Market Cap		Get a 7-Day Free Trial					-	-	-	-	-

Aevi Genomic Medicine Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Market Cap	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Aevi Genomic Medicine's Market Cap

For the Biotechnology subindustry, Aevi Genomic Medicine's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aevi Genomic Medicine's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aevi Genomic Medicine's Market Cap distribution charts can be found below:

* The bar in red indicates where Aevi Genomic Medicine's Market Cap falls into.

Aevi Genomic Medicine Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Aevi Genomic Medicine's Market Cap for the fiscal year that ended in Dec. 2018 is calculated as

Aevi Genomic Medicine's Market Cap for the quarter that ended in Sep. 2019 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aevi Genomic Medicine  (LSE:MEDU) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Aevi Genomic Medicine Market Cap Related Terms

Thank you for viewing the detailed overview of Aevi Genomic Medicine's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Aevi Genomic Medicine (LSE:MEDU) Business Description